www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for August, 2009

Researchers in Singapore are reporting development of a new electronic sensor that shows promise as a faster, less expensive, and more practical alternative than tests now used to detect DNA. Such tests are done for criminal investigation, disease diagnosis, and other purposes. The new lab-on-a-chip test could lead to wider, more convenient use of DNA testing, the researchers say. Their study is scheduled for the Sept.
Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Large variations exist in peoples’ ability to eliminate arsenic from the body, according to a new study that questions existing standards for evaluating the human health risks from the potentially toxic substance. The study found that some people eliminate more than 90 percent of the arsenic consumed in the diet. Others store arsenic in their bodies, where it can have harmful effects. The research, based on the first application of new methods for studying arsenic, is scheduled for the Sept.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • A new analysis of 20 years of data contradicts previously published claims that United States pharmaceutical companies are better innovators than their European counterparts, and questions whether Americans actually benefit from the higher prices they pay for many prescription medications. The re-analysis by Donald W. Light, PhD, a professor of social medicine and comparative health systems at the UMDNJ-School of Osteopathic medicine, appears in the current Health Affairs-web exclusive.
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Sanofi-aventis said Thursday that it will close its Kansas City manufacturing facility. The operation employs about 370 workers, a company spokesman said.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Economist and investor John P. Hussman pledged a $20 million gift to fuel genetic research at the University of Miami Miller School of Medicine

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • After seeing a run in its stock because of takeover rumors, Human Genome Sciences Inc. shares took a hit Thursday morning from news that its hailed lupus drug candidate could have a potential rival in the making. (IMMU)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Lucette Crane Systems of Cincinnati and Lilli Crane & Equipment of Dayton have formed a partnership to sell and service electric overhead traveling cranes.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Demonstrating a significant commitment to advancing the quality of medicines for patients on behalf of both countries, the U.S. Pharmacopeial (USP) Convention and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) today agreed to collaborate on the development of standards for medicines. These standards are a key component of public health, helping to ensure the identity, quality, purity, strength and consistency of medicines that patients rely on every day.
    Lees meer..

  • 0 Comments
  • Filed under: Pharmaceuten
  • The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) reached a favorable agreement with the Delaware State Department of Health and Social Services that will restore much of the funding that would have been lost due to rate cuts in Medicaid reimbursement to pharmacists. The associations joined together in filing a
    Lees meer..

  • 0 Comments
  • Filed under: Pharmaceuten